Abstract
The precise molecular structure of the antigenic determinant recognized by the T-cell receptor of the CD4-positive cell has not been completely resolved. A major advance in our understanding of this issue has been made by our demonstration of a direct association between an immunogenic peptide and a purified Ia molecule1. The most likely and economical hypothesis is that antigen binds directly to an Ia molecule creating the antigenic determinant and that this antigen-Ia complex is recognized by the T-cell receptor. We examined in detail a determinant of hen egg-white lysozyme (HEL) contained in the tryptic fragment HEL(46–61), recognized by T cells in H-2k strains of mice2,3. This peptide binds with a Kd of ˜3 μM to I-Ak molecules1. We have already ascertained that (1) the 10-mer HEL(52–61) is the shortest stimulatory peptide4; (2) the Leu56 residue, the only residue different from mouse lysozyme, is responsible for the immunogenicity4; (3) the Leu56 and Tyr53 residues are critical for recognition by the T-cell receptor5 and (4) HEL(46–61) generates multiple determinants when it associated with the I-Ak molecule4,6. If antigen and Ia interact, the antigen must have two features: it must bind to an Ia molecule and also interact with the T-cell receptor7,8. The two sites do not appear to be laterally separable in this peptide5 and are therefore probably composed of distinct but interspersed amino-acid residues. We have now identified the three residues of HEL(52–61) that contact the T-cell receptor and three other residues that contact the I-Ak molecule. From modelling studies we also propose that HEL(52–61) assumes an α-helical conformation as it is bound to I-Ak and recognized by the T-cell receptor.
Similar content being viewed by others
References
1. Babbitt, B., Alien, P. M., Matsueda, G., Haber, E. & Unanue, E. R. Nature 317, 359–3(31 (1985).
2. Alien, P. M. & Unanue, E. R. /. Immun. 132, 1077–1079 (1984).
3. Alien, P. M., Strydom, D. J. & Unanue, E. R. Proc. natn. Acad. Sci. U.S.A. 81, 2489–2493 (1984).
4. Alien, P. M., Matsueda, G. R., Haber, E. & Unanue, E. R. J. Immun. 135, 368–373 (198?)).
5. Babbitt, B. P., Matsueda, G. R., Haber, E., Unanue, E. R. & Alien, P. M. Proc. natn. Acad. Sci. U.S.A. 83, 4509–4513 (1986).
6. Alien, P. M., McKean, D. J., Beck, B. N., Sheffield, J. & Glimcher, L. H. /. exp. Med. 162, 1264–1274 (1985).
7. Rosenthal, A. S. Immun. Rev. 40, 136–152 (1978).
8. Heber–Katz, E., Hansburg, D. & Schwartz, R. H. J. molec. cell. Immun. 1, 3–9 (1983).
9. Kronenberg, M., Siu, G., Hood, L. E. & Shastri, N. A. Rev. Immun. 4, 529–591 (1986).
10. Pincus, M. R., Gerewitz, F., Schwartz, R. H. & Scheraga, H. Proc. natn. Acad. Sci. U.S.A. 80, 3297–3301 (1983).
11. Spouge, J. L. et al. J. Immun. 138, 204–212 (1987).
12. Carbone, F. R., Fox, B. S., Schwartz, R. H. & Paterson, Y. /. Immun. 138,1838–1844 (1987).
13. Blake, C. C. et al. Nature 206, 757–760 (1965).
14. Buus, S., Sette, A., Colon, S. M., Jenis, D. M. & Grey, H. M. Cell 47, 1071–1077 (1986).
15. Hansburg, D., Heber–Katz, E., Fairvell, T. & Apella, T. J. exp. Med. 158, 25–39 (1983).
16. Watts, T. H., Gariepy, J., Schoolnik, G. K. & McConnell, H. M. Proc. natn. Acad. Sci. U.S.A. 82, 5480–5484 (1985).
17. Berkower, I. J., Buckenmeyer, G. K. & Berzofsky, J. A. J. Immun. 136, 2498–2503 (1986).
18. Guillet, J–G. et al. Science 235, 865–870 (1987).
19. Buus, S., Sette, A., Colon, S. M., Miles, C. & Grey, H. M. Science 235, 1353–1358 (1987)'.
20. Weiner, S. J., Kollman, P. A., Nguyen, D. T. & Case, D. A. J. comput. Chem. 7,230–252 (1986).
21. Nader, J. A. & Mead, R. Comp. J. 7, 308–313 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allen, P., Matsueda, G., Evans, R. et al. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327, 713–715 (1987). https://doi.org/10.1038/327713a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327713a0
- Springer Nature Limited
This article is cited by
-
Cancer immunotherapy: it’s time to better predict patients’ response
British Journal of Cancer (2021)
-
Evidence of genetic epistasis in autoimmune diabetes susceptibility revealed by mouse congenic sublines
Immunogenetics (2021)
-
An orthologous non-MHC locus in rats and mice is linked to CD4+ and CD8+ T-cell proportion
Genes & Immunity (2017)
-
RAFTsomes Containing Epitope-MHC-II Complexes Mediated CD4+ T Cell Activation and Antigen-Specific Immune Responses
Pharmaceutical Research (2013)
-
Interleukin‐10 limits the expansion of immunoregulatory CD4−CD8− T cells in autoimmune‐prone non‐obese diabetic mice
Immunology & Cell Biology (2010)